Description
In this issue of Neurologic Clinics, guest editors Drs. Aziz Shaibani and Fabrizio Benedetti bring their considerable expertise to the topic of Placebo Responses in Neurologic Clinical Trials. Top experts discuss the placebo response (not just the placebo effect) across a variety of neurologic clinical trials, providing an important overview of the occurrence and magnitude of the placebo response in different neurologic disorders. This issue offers key information for clinical trials in neurology as well as for clinical practice.- Contains 12 relevant, practice-oriented topics including definitions of placebo effect and placebo response; placebo responses in clinical trials of anti-migraine drugs; placebo responses in trials of Parkinson's disease; placebo responses in clinical trials of epilepsy; placebo responses in trials for multiple sclerosis; Harnessing the placebo effect in clinical practice; and more- Provides in-depth clinical reviews on placebo responses in neurologic clinical trials, offering actionable insights for clinical practice- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Table of Contents
Placebo Response and Placebo Effect: What Is the Difference?Placebo Responses in Clinical Trials of AnalgesicsPlacebo Response in Acute and Prophylactic Treatment of Migraine: A Systematic Review and Meta-Analysis Covering 36 Years of ResearchPlacebo Responses in Trials of Parkinson's DiseasePlacebo Effects in the Treatment of Depression—Implications for the Psychedelic RenaissanceEpilepsy and Placebo: A Literature ReviewPlacebo Responses in Trials for Multiple Sclerosis Placebo Responses in Trials of Functional Neurologic DisordersAn Overview of Nocebo Adverse Events in Clinical TrialsHarnessing the Placebo Effect in Clinical Practice
